266 related articles for article (PubMed ID: 6998487)
1. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G
Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487
[TBL] [Abstract][Full Text] [Related]
2. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
3. [Cross-over double-blind study of the antihypertensive action of N-amidino-2-(2,6-dichlorophenyl)acetamide-hydrochloride and clonidine].
Kirch W; Distler A
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():318-21. PubMed ID: 347806
[No Abstract] [Full Text] [Related]
4. [A new antihypertensive agent used in a clinical setting].
Wetzels E; Raschig A; Kaiser HJ
Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effect of N-amidino-2-(2,6-dichlorophenyl) acetamide hydrochloride. A double-blind cross-over trial versus clonidine.
Kirch W; Distler A
Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):132-5. PubMed ID: 348614
[TBL] [Abstract][Full Text] [Related]
6. A new centrally action antihypertensive agent guanfacine (BS 100-141).
Dubach UC; Huwyler R; Radielovic P; Singeisen M
Arzneimittelforschung; 1977; 27(3):674-6. PubMed ID: 326262
[TBL] [Abstract][Full Text] [Related]
7. Guanfacine: a new centrally-acting antihypertensive agent.
Beevers DG; Bloxham CA; Walker JM
Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
[TBL] [Abstract][Full Text] [Related]
8. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
Schäfer N; Knaup G
Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
[No Abstract] [Full Text] [Related]
9. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
Rosenthal J; Jäger H
MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
[TBL] [Abstract][Full Text] [Related]
10. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
11. A postmarketing evaluation of guanfacine hydrochloride in mild to moderate hypertension.
Board AW; Perry VP; Shepperson BE; Nyman CE; Carchman SH
Clin Ther; 1988; 10(6):761-75. PubMed ID: 3064907
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical experience with guanfacine.
Fetkovská N; Brimichová G; Sebeková K; Dzúrik R
Cor Vasa; 1987; 29(4 Suppl 1):23-9. PubMed ID: 3315447
[TBL] [Abstract][Full Text] [Related]
13. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
Rhomberg F; Widler J
Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
[TBL] [Abstract][Full Text] [Related]
14. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)].
Rosenthal J; Schäfer N; Rauh J; Raschig A
Dtsch Med Wochenschr; 1980 Nov; 105(48):1680-4. PubMed ID: 7002524
[TBL] [Abstract][Full Text] [Related]
15. [Guanfacine in primary arterial hypertension: a long-term open clinical study].
Román O; Valenzuela MA; Salazar R
Rev Med Chil; 1982 Dec; 110(12):1179-84. PubMed ID: 6764015
[No Abstract] [Full Text] [Related]
16. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
Jerie P; Lasance A
Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):279-87. PubMed ID: 7030975
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and tolerance of the antihypertensive agent guanfacine.
Jerie P; Lasance A
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):170-4. PubMed ID: 6370876
[TBL] [Abstract][Full Text] [Related]
18. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
Mayer O; Polívková H
Cor Vasa; 1987; 29(4 Suppl 1):37-41. PubMed ID: 3315449
[TBL] [Abstract][Full Text] [Related]
19. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
Jiménez Casado M; Canto J; Yapur H; Oller JM
Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
[No Abstract] [Full Text] [Related]
20. Examination of the antihypertensive action of long-term estulic (Egis-Sandoz) treatment.
Zeher M; Antal L; Azad AQ; Szegedi G
Ther Hung; 1988; 36(3):103-8. PubMed ID: 3074520
[No Abstract] [Full Text] [Related]
[Next] [New Search]
